Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Pediatric Brain Tumor Consortium
ClinicalTrials.gov Identifier:
NCT00098761
First received: December 8, 2004
Last updated: June 29, 2011
Last verified: June 2011